Literature DB >> 35773554

The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.

G Defeudis1, M Rossini2, Y M Khazrai3, A M V Pipicelli4, G Brucoli2, M Veneziano2, F Strollo5, A Bellia, O Bitterman, D Lauro, D Mora, E Santarelli.   

Abstract

Several studies have shown a strong correlation between the different types of diets and gut microbiota composition on glycemia and weight loss. In this direction, low-carbohydrate and ketogenic diets have gained popularity, despite studies published so far leading to controversial results on subjects with diabetes. In this narrative review, firstly, we aimed to analyze the role of very-low-calorie ketogenic diets (VLCKDs) in type 2 diabetes (T2DM) and obesity management. Secondly, in this context, we focused attention on gut microbiota as a function of VLCKD, particularly in T2DM and obesity treatment. Finally, we reported all this evidence to underline the importance of gut microbiota to exalt new nutritional strategies for "tailor-made" management, treatment, and rehabilitation in subjects with T2DM and obesity, even with diabetic complications. In conclusion, this narrative review outlined the beneficial impact of VLCKD on gut microbiota even in subjects with T2DM and obesity, and, despite inner VLCKD short-duration feature allowing no sound-enough provisions for long-term outcomes, witnessed in favor of the short-term safety of VLCKD in those patients.Level of evidence Level V: Opinions of authorities, based on descriptive studies, narrative reviews, clinical experience, or reports of expert committees.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Diabetes; Gut microbiota; Obesity; Rehabilitation; VLCKDs; Very low-calorie ketogenic diet

Mesh:

Substances:

Year:  2022        PMID: 35773554     DOI: 10.1007/s40519-022-01434-2

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   3.008


  41 in total

Review 1.  Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes.

Authors:  Scott Baker; George Jerums; Joseph Proietto
Journal:  Diabetes Res Clin Pract       Date:  2009-06-27       Impact factor: 5.602

2.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

3.  Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

Authors:  Michael Ej Lean; Wilma S Leslie; Alison C Barnes; Naomi Brosnahan; George Thom; Louise McCombie; Carl Peters; Sviatlana Zhyzhneuskaya; Ahmad Al-Mrabeh; Kieren G Hollingsworth; Angela M Rodrigues; Lucia Rehackova; Ashley J Adamson; Falko F Sniehotta; John C Mathers; Hazel M Ross; Yvonne McIlvenna; Renae Stefanetti; Michael Trenell; Paul Welsh; Sharon Kean; Ian Ford; Alex McConnachie; Naveed Sattar; Roy Taylor
Journal:  Lancet       Date:  2017-12-05       Impact factor: 79.321

4.  12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.

Authors:  Boris Draznin; Vanita R Aroda; George Bakris; Gretchen Benson; Florence M Brown; RaShaye Freeman; Jennifer Green; Elbert Huang; Diana Isaacs; Scott Kahan; Jose Leon; Sarah K Lyons; Anne L Peters; Priya Prahalad; Jane E B Reusch; Deborah Young-Hyman
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 19.112

Review 5.  Spontaneous Physical Activity Defends Against Obesity.

Authors:  Catherine M Kotz; Claudio E Perez-Leighton; Jennifer A Teske; Charles J Billington
Journal:  Curr Obes Rep       Date:  2017-12

6.  IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.

Authors:  Hong Sun; Pouya Saeedi; Suvi Karuranga; Moritz Pinkepank; Katherine Ogurtsova; Bruce B Duncan; Caroline Stein; Abdul Basit; Juliana C N Chan; Jean Claude Mbanya; Meda E Pavkov; Ambady Ramachandaran; Sarah H Wild; Steven James; William H Herman; Ping Zhang; Christian Bommer; Shihchen Kuo; Edward J Boyko; Dianna J Magliano
Journal:  Diabetes Res Clin Pract       Date:  2021-12-06       Impact factor: 5.602

Review 7.  The diabesity epidemic in the light of evolution: insights from the capacity-load model.

Authors:  Jonathan C K Wells
Journal:  Diabetologia       Date:  2019-08-27       Impact factor: 10.122

Review 8.  Scientific evidence underlying contraindications to the ketogenic diet: An update.

Authors:  Mikiko Watanabe; Dario Tuccinardi; Ilaria Ernesti; Sabrina Basciani; Stefania Mariani; Alfredo Genco; Silvia Manfrini; Carla Lubrano; Lucio Gnessi
Journal:  Obes Rev       Date:  2020-07-10       Impact factor: 9.213

9.  Very-Low-Calorie Ketogenic Diet as a Safe and Valuable Tool for Long-Term Glycemic Management in Patients with Obesity and Type 2 Diabetes.

Authors:  Eleonora Moriconi; Elisabetta Camajani; Andrea Fabbri; Andrea Lenzi; Massimiliano Caprio
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.